Head of Innovation Strategies & External Liaison within
AstraZeneca pharmaceutical organization
Stanko Skrtic is Head of Innovation Strategies & External Liaison within AstraZeneca pharmaceutical organization. IS&EL is a team of Life Science professionals that drives and champions science and innovation in pharmaceutical technologies with the aim to create new implementable business opportunities. Stanko has a broad background in drug development and also from business development ventures as being the founding innovator in several small Life Science companies.
Stanko has been with AstraZeneca for 14 years and has a background as physician with a PhD in molecular endocrinology from Gothenburg University. He has been an associate professor in clinical pharmacology for more than 10 years.
Stanko gave a joint presentation with AstraZeneca colleague Jonas Johansson about AstraZeneca’s pharmaceutical technology innovation organization, partnering model and show different examples of how we interact with the life science industry around us.
Theme: Swedish Life Science